Technology-enabled pulmonary clinic network. Nimbus Health is building the future of pulmonary care.
Series Seed II Round (5/14/25): $7,650,000 Round on $50M post priced. 2048 leading with $6M and 8VC $1M. Our SAFE converted to 83,268 shares at $2.3112 share price Seed SAFE Extension Round: $2M at $32.5M SAFE with 20% discount Seed SAFE Round: $2. SH committed $250K, via StoryHouse Fund I, at a $19.5M valuation, in a $4.8M round, alongside 2048 Ventures, K50 Ventures, 8VC, Four Acres Capital.
RAW NOTES: General \- Biggest positive update is that they may have found a pulmonologist. She's verbally agreed to financial terms and likely to start on March 1st. He's going to bring her on for 2 weeks a month to start, then they'll recruit someone local in Columbus, then she'll open the second...
Source: Meeting Notes rec5WO6GJHHnGCdT5
THIS IS A DATED CALL NOTE FROM MAY 31ST 2022. PLEASE ADD IT TO THE NIMBUS DEAL. FOUNDER NAME: Clay Spense LAST TOUCHPOINT?: ROUND: Seed SOURCE OF INTEL: SH Team SOURCE OF INTRO: SH Team INTRODUCER/TEAM MEMBER (IF APPLICABLE): Miles Bird DEAL STATUS: In Conversation REASON FOR PASSING (IF...
Source: Meeting Notes recBJ5GiaivyiM2kX